The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial.
Saved in:
| Title: | The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial. |
|---|---|
| Authors: | Nordlund J; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada., Henry RS; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada.; Department of Psychiatry, McGill University, Montreal, Quebec, Canada., Kwakkenbos L; Department of Clinical Psychology, Radboud University, Nijmegen, The Netherlands.; Department of Medical Psychology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Carrier ME; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada., Levis B; Centre for Prognosis Research, School of Medicine, Keele University, Keele, Staffordshire, UK., Nielson WR; St. Joseph's Health Care, London, Ontario, Canada., Bartlett SJ; Department of Medicine, McGill University, Montreal, Quebec, Canada.; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Dyas L; Scleroderma Foundation, Michigan Chapter, Southfield, MI, USA., Tao L; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada., Fedoruk C; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada., Nielsen K; Scleroderma Society of Ontario, Hamilton, Ontario, Canada., Hudson M; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, Quebec, Canada., Pope J; Department of Medicine, University of Western Ontario, London, Ontario, Canada., Frech T; Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA., Gholizadeh S; California School of Professional Psychology/Alliant, Los Angeles, CA, USA., Johnson SR; Toronto Scleroderma Program, Mount Sinai Hospital & Toronto Western Hospital, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada., Piotrowski P; Private practice - Nutrition, Milton, Ontario, Canada., Jewett LR; Department of Psychology, Jewish General Hospital, Montreal, Quebec, Canada., Gordon J; Department of Medicine, Hospital for Special Surgery, New York City, NY, USA., Chung L; Department of Medicine, Stanford University, Palo Alto, CA, USA.; Department of Medicine, Palo Alto VA Health Care System, Palo Alto, CA, USA., Bilsker D; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada., Levis AW; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Turner KA; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada., Cumin J; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada., Welling J; NVLE Dutch patient organization for systemic autoimmune diseases, Utrecht, The Netherlands., Fortuné C; Ottawa Scleroderma Support Group, Ottawa, Ontario, Canada., Leite C; University of Minho, Braga, Portugal., Gottesman K; Scleroderma Foundation, Los Angeles, CA, USA., Sauve M; Scleroderma Society of Ontario, Hamilton, Ontario, Canada.; Scleroderma Canada, Hamilton, Ontario, Canada., Rodríguez-Reyna TS; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Larche M; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., van Breda W; Faculty of Behavioural and Movement Sciences, VU University, Amsterdam, The Netherlands., Suarez-Almazor ME; Department of General Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wurz A; School of Kinesiology, University of the Fraser Valley, Chilliwack, British Columbia, Canada., Culos-Reed N; Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.; Department of Oncology, Cumming School of Medicine, Calgary, Canada.; Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada., Malcarne VL; Department of Psychology, San Diego State University, San Diego, CA, USA.; Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California San Diego, San Diego, CA, USA., Mayes MD; Department of Internal Medicine, University of Texas McGovern School of Medicine, Houston, TX, USA., Boutron I; Université de Paris, Centre of Research Epidemiology and Statistics (CRESS), Inserm, INRA, Paris, France.; Centre d'Épidémiologie Clinique, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Hôtel Dieu, Paris, France., Mouthon L; Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; APHP-CUP, Hôpital Cochin, Université de Paris, F-75014, Paris, France., Benedetti A; Department of Medicine, McGill University, Montreal, Quebec, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada., Thombs BD; Lady Davis Institute of the Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, Quebec, H3T 1E2, Canada. brett.thombs@mcgill.ca.; Department of Psychiatry, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.; Department of Medicine, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.; Department of Psychology, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.; Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca.; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca. |
| Corporate Authors: | SPIN Investigators |
| Source: | Trials [Trials] 2021 Nov 27; Vol. 22 (1), pp. 856. Date of Electronic Publication: 2021 Nov 27. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1745-6215 |
|---|---|
| DOI: | 10.1186/s13063-021-05827-z |
